2021 Microbiome Market Trend

Abstract
Microbiome (microbiome genomic information) development in research have shown that many diseases and changes in health are associated with the transformation of the microbiome. For this reason, several applications research is underway such as diagnosis, analysis, and testing, as well as development of therapeutics, functional foods, and agricultural, livestock, and fisheries applications.

The spread of the new coronavirus infection (COVID-19) has led to delays in clinical trials and stagnation of investment activities, which has become a factor that increases the risk of continuity of development. However, as the COVID-19 problem raises people's interest in health and some companies position their strategy as developments to combat COVID-19 infection and aims to launch a product that enables a strong immune response.

This report focuses on the efforts of start-up companies involved in the microbiome market and covers a wide range of areas from market size to technology trends, sequencing, functional foods, agriculture, livestock and fisheries, regulations, and marketing.

It covers regional analysis, technology, application, major players and competitive environment insights.
Regional Segment Analysis
United States
Canada
Germany
France
Italy
UK
China
Japan
India
Brazil
Others

Technology trend analysis : Technology segment
Fecal Microbiota Transplantation
Encapsulation technology
Microbiome sampling capsule
Sequencing

Microbiome application : Application segment
Therapeutic
Diagnosis
Functional food
Skin Care
Agriculture, livestock and fisheries

Content
2021 Microbiome Market Trend

Chapter 1 Microbiome Market Trend
1.1 Microbiome Market Background
1.2 Applications overview
Covid-19 and Microbiome
Probiotics attracting attention again
Sequencing

Chapter 2 Microbiome Technology Trend
2.1 Fecal Microbiota Transplantation
2.2 Encapsulation Technology
2.3 Microbiome Sampling capsule
2.4 Sequencing
2.4.1) 16S rRNA Sequencing
2.4.2) Shotgun Metagenome Analysis
2.4.3) Metabolome Analysis
2.4.4) Integrated Omics Analysis

Chapter 3 Analysis by Microbiome Application
3.1 Therapeutic
3.1.1) Gastrointestinal Disease (C. Difficile、Inflammatory Bowel Disease)
3.1.2) Liver Disease System (non-alcoholic fatty liver)
3.1.3) Metabolic Disorders (Obesity, Diabetes, etc.)
3.1.4) Cancer Diseases (Colorectal Cancer, Liver Cancer)
3.1.5) Immune Disease System (type 1 diabetes, Psoriasis,etc.)
3.1.6) Brain and Nervous System Diseases (Alzheimer's Disease, Parkinson's Disease)
3.2 Diagnosis
3.2.1) Diagnostic Kit
3.2.2) MGI's Presence in Sequencing
3.2.3) What is Required of Sequencing Technology
3.3 Functional Food
3.3.1) Probiotics, Prebiotics
3.3.2) Functional Food Market in China
3.4 Skin Care
3.4.1) Microbiome and Skin Care
3.4.2) L’Oréal、Gallinée
3.5 Agriculture, Livestock and Fisheries
3.6 Others

Chapter 4 Supply chain
4.1 Microbiome and Industry Segment
4.2 Stool Bank and Microbiome

Chapter 5 Competitive Environment Analysis
5.1 Analysis of Major Market Entrants
5.1.1) Evelo Biosciences
5.1.2) Seres Therapeutics
5.1.3) Rebiotix
5.1.4) DuPont
5.1.5) Yakult
5.1.6) Morinaga
5.2 Competitive Leadership Mapping

Chapter 6. Market Scale Projection

Chapter 7. Microbiome and Marketing Strategy
7.1 Increasing interest in health with after-corona
7.2 Regulations and Issues
7.3 Consideration on Marketing Strategy

Chapter 8. Conclusion

List of Tables and Figures
Numbers of Microbiome Gut Microbiome Studies
Major Development of Microbiome Therapeutics
Financing of Gut Microbiome Related Companies
Example of Probiotics Lactobacillus strains
Merit and Demerit of microbiota sampling cuspules
Probiotics, Prebiotics and Postbiotics
Probiotics Market Value in China
Gallinée Products Comparison
Microbiome and Agriculture
Competitive Leadership Mapping
Microbiome Therapeutics Market by Disease (Million USD)
Probiotics, Prebiotics Market (Million USD)
Microbiome Market by Application(Million USD)
Microbiome Market by Area (Million USD)